Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | yes | yes: 4 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 8 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0000118 | histone deacetylase complex | 3 | 2 |
GO:0000123 | histone acetyltransferase complex | 4 | 12 |
GO:0000812 | Swr1 complex | 4 | 2 |
GO:0005654 | nucleoplasm | 2 | 2 |
GO:0005737 | cytoplasm | 2 | 2 |
GO:0031011 | Ino80 complex | 5 | 12 |
GO:0031248 | protein acetyltransferase complex | 3 | 12 |
GO:0031974 | membrane-enclosed lumen | 2 | 2 |
GO:0031981 | nuclear lumen | 5 | 2 |
GO:0032838 | plasma membrane bounded cell projection cytoplasm | 4 | 2 |
GO:0032991 | protein-containing complex | 1 | 12 |
GO:0035267 | NuA4 histone acetyltransferase complex | 7 | 12 |
GO:0043189 | H4/H2A histone acetyltransferase complex | 6 | 12 |
GO:0043233 | organelle lumen | 3 | 2 |
GO:0070013 | intracellular organelle lumen | 4 | 2 |
GO:0070603 | SWI/SNF superfamily-type complex | 3 | 12 |
GO:0097014 | ciliary plasm | 5 | 2 |
GO:0097255 | R2TP complex | 2 | 12 |
GO:0097346 | INO80-type complex | 4 | 12 |
GO:0099568 | cytoplasmic region | 3 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
GO:0140513 | nuclear protein-containing complex | 2 | 12 |
GO:0140535 | intracellular protein-containing complex | 2 | 12 |
GO:1902493 | acetyltransferase complex | 4 | 12 |
GO:1902494 | catalytic complex | 2 | 12 |
GO:1902562 | H4 histone acetyltransferase complex | 5 | 12 |
GO:1904949 | ATPase complex | 3 | 12 |
GO:1990234 | transferase complex | 3 | 12 |
Related structures:
AlphaFold database: Q4Q2J4
Term | Name | Level | Count |
---|---|---|---|
GO:0000491 | small nucleolar ribonucleoprotein complex assembly | 7 | 2 |
GO:0000492 | box C/D snoRNP assembly | 8 | 2 |
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 12 |
GO:0006259 | DNA metabolic process | 4 | 12 |
GO:0006281 | DNA repair | 5 | 12 |
GO:0006325 | chromatin organization | 4 | 2 |
GO:0006338 | chromatin remodeling | 5 | 2 |
GO:0006355 | regulation of DNA-templated transcription | 6 | 2 |
GO:0006357 | regulation of transcription by RNA polymerase II | 7 | 2 |
GO:0006473 | protein acetylation | 6 | 2 |
GO:0006475 | internal protein amino acid acetylation | 7 | 2 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 12 |
GO:0006807 | nitrogen compound metabolic process | 2 | 12 |
GO:0006950 | response to stress | 2 | 12 |
GO:0006974 | DNA damage response | 4 | 12 |
GO:0008152 | metabolic process | 1 | 12 |
GO:0009889 | regulation of biosynthetic process | 4 | 2 |
GO:0009987 | cellular process | 1 | 12 |
GO:0010468 | regulation of gene expression | 5 | 2 |
GO:0010556 | regulation of macromolecule biosynthetic process | 5 | 2 |
GO:0016043 | cellular component organization | 3 | 2 |
GO:0016570 | histone modification | 5 | 2 |
GO:0016573 | histone acetylation | 6 | 2 |
GO:0018193 | peptidyl-amino acid modification | 5 | 2 |
GO:0018205 | peptidyl-lysine modification | 6 | 2 |
GO:0018393 | internal peptidyl-lysine acetylation | 8 | 2 |
GO:0018394 | peptidyl-lysine acetylation | 7 | 2 |
GO:0019219 | regulation of nucleobase-containing compound metabolic process | 5 | 2 |
GO:0019222 | regulation of metabolic process | 3 | 2 |
GO:0019538 | protein metabolic process | 3 | 2 |
GO:0022607 | cellular component assembly | 4 | 2 |
GO:0022618 | ribonucleoprotein complex assembly | 6 | 2 |
GO:0031323 | regulation of cellular metabolic process | 4 | 2 |
GO:0031326 | regulation of cellular biosynthetic process | 5 | 2 |
GO:0033554 | cellular response to stress | 3 | 12 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 12 |
GO:0036211 | protein modification process | 4 | 2 |
GO:0043170 | macromolecule metabolic process | 3 | 12 |
GO:0043412 | macromolecule modification | 4 | 2 |
GO:0043543 | protein acylation | 5 | 2 |
GO:0043933 | protein-containing complex organization | 4 | 2 |
GO:0044237 | cellular metabolic process | 2 | 12 |
GO:0044238 | primary metabolic process | 2 | 12 |
GO:0044260 | obsolete cellular macromolecule metabolic process | 3 | 12 |
GO:0046483 | heterocycle metabolic process | 3 | 12 |
GO:0050789 | regulation of biological process | 2 | 2 |
GO:0050794 | regulation of cellular process | 3 | 2 |
GO:0050896 | response to stimulus | 1 | 12 |
GO:0051171 | regulation of nitrogen compound metabolic process | 4 | 2 |
GO:0051252 | regulation of RNA metabolic process | 5 | 2 |
GO:0051716 | cellular response to stimulus | 2 | 12 |
GO:0060255 | regulation of macromolecule metabolic process | 4 | 2 |
GO:0065003 | protein-containing complex assembly | 5 | 2 |
GO:0065007 | biological regulation | 1 | 2 |
GO:0071704 | organic substance metabolic process | 2 | 12 |
GO:0071826 | ribonucleoprotein complex subunit organization | 5 | 2 |
GO:0071840 | cellular component organization or biogenesis | 2 | 2 |
GO:0080090 | regulation of primary metabolic process | 4 | 2 |
GO:0090304 | nucleic acid metabolic process | 4 | 12 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 12 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 2 |
GO:1903506 | regulation of nucleic acid-templated transcription | 7 | 2 |
GO:2001141 | regulation of RNA biosynthetic process | 6 | 2 |
Term | Name | Level | Count |
---|---|---|---|
GO:0000166 | nucleotide binding | 3 | 12 |
GO:0003678 | DNA helicase activity | 3 | 12 |
GO:0003824 | catalytic activity | 1 | 12 |
GO:0004386 | helicase activity | 2 | 12 |
GO:0005488 | binding | 1 | 12 |
GO:0005524 | ATP binding | 5 | 12 |
GO:0008094 | ATP-dependent activity, acting on DNA | 2 | 12 |
GO:0016462 | pyrophosphatase activity | 5 | 12 |
GO:0016787 | hydrolase activity | 2 | 12 |
GO:0016817 | hydrolase activity, acting on acid anhydrides | 3 | 12 |
GO:0016818 | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | 4 | 12 |
GO:0016887 | ATP hydrolysis activity | 7 | 12 |
GO:0017076 | purine nucleotide binding | 4 | 12 |
GO:0017111 | ribonucleoside triphosphate phosphatase activity | 6 | 12 |
GO:0030554 | adenyl nucleotide binding | 5 | 12 |
GO:0032553 | ribonucleotide binding | 3 | 12 |
GO:0032555 | purine ribonucleotide binding | 4 | 12 |
GO:0032559 | adenyl ribonucleotide binding | 5 | 12 |
GO:0035639 | purine ribonucleoside triphosphate binding | 4 | 12 |
GO:0036094 | small molecule binding | 2 | 12 |
GO:0043167 | ion binding | 2 | 12 |
GO:0043168 | anion binding | 3 | 12 |
GO:0097159 | organic cyclic compound binding | 2 | 12 |
GO:0097367 | carbohydrate derivative binding | 2 | 12 |
GO:0140097 | catalytic activity, acting on DNA | 3 | 12 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 2 | 12 |
GO:0140657 | ATP-dependent activity | 1 | 12 |
GO:1901265 | nucleoside phosphate binding | 3 | 12 |
GO:1901363 | heterocyclic compound binding | 2 | 12 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 144 | 148 | PF00656 | 0.471 |
CLV_NRD_NRD_1 | 120 | 122 | PF00675 | 0.271 |
CLV_PCSK_KEX2_1 | 120 | 122 | PF00082 | 0.271 |
CLV_PCSK_KEX2_1 | 204 | 206 | PF00082 | 0.271 |
CLV_PCSK_PC1ET2_1 | 204 | 206 | PF00082 | 0.271 |
CLV_PCSK_SKI1_1 | 171 | 175 | PF00082 | 0.289 |
CLV_PCSK_SKI1_1 | 424 | 428 | PF00082 | 0.210 |
CLV_PCSK_SKI1_1 | 67 | 71 | PF00082 | 0.271 |
CLV_PCSK_SKI1_1 | 79 | 83 | PF00082 | 0.271 |
DEG_APCC_KENBOX_2 | 127 | 131 | PF00400 | 0.532 |
DEG_SPOP_SBC_1 | 9 | 13 | PF00917 | 0.587 |
DOC_ANK_TNKS_1 | 379 | 386 | PF00023 | 0.471 |
DOC_CKS1_1 | 411 | 416 | PF01111 | 0.483 |
DOC_CYCLIN_RxL_1 | 21 | 32 | PF00134 | 0.471 |
DOC_CYCLIN_yCln2_LP_2 | 411 | 417 | PF00134 | 0.483 |
DOC_MAPK_gen_1 | 120 | 127 | PF00069 | 0.471 |
DOC_MAPK_gen_1 | 165 | 175 | PF00069 | 0.471 |
DOC_MAPK_gen_1 | 47 | 56 | PF00069 | 0.472 |
DOC_MAPK_MEF2A_6 | 120 | 127 | PF00069 | 0.471 |
DOC_MAPK_MEF2A_6 | 155 | 164 | PF00069 | 0.483 |
DOC_MAPK_MEF2A_6 | 49 | 58 | PF00069 | 0.471 |
DOC_MAPK_MEF2A_6 | 79 | 86 | PF00069 | 0.471 |
DOC_MAPK_MEF2A_6 | 88 | 96 | PF00069 | 0.471 |
DOC_MAPK_NFAT4_5 | 120 | 128 | PF00069 | 0.471 |
DOC_MAPK_NFAT4_5 | 79 | 87 | PF00069 | 0.471 |
DOC_PP1_RVXF_1 | 65 | 72 | PF00149 | 0.471 |
DOC_PP4_FxxP_1 | 71 | 74 | PF00568 | 0.471 |
DOC_SPAK_OSR1_1 | 406 | 410 | PF12202 | 0.410 |
DOC_USP7_MATH_1 | 19 | 23 | PF00917 | 0.464 |
DOC_USP7_MATH_1 | 251 | 255 | PF00917 | 0.576 |
DOC_USP7_MATH_1 | 321 | 325 | PF00917 | 0.471 |
DOC_USP7_UBL2_3 | 284 | 288 | PF12436 | 0.471 |
DOC_WW_Pin1_4 | 410 | 415 | PF00397 | 0.471 |
LIG_14-3-3_CanoR_1 | 205 | 213 | PF00244 | 0.471 |
LIG_14-3-3_CanoR_1 | 268 | 278 | PF00244 | 0.557 |
LIG_Actin_RPEL_3 | 399 | 418 | PF02755 | 0.471 |
LIG_Actin_WH2_2 | 303 | 321 | PF00022 | 0.471 |
LIG_Actin_WH2_2 | 392 | 408 | PF00022 | 0.471 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.591 |
LIG_BRCT_BRCA1_1 | 403 | 407 | PF00533 | 0.576 |
LIG_Clathr_ClatBox_1 | 172 | 176 | PF01394 | 0.576 |
LIG_FHA_1 | 110 | 116 | PF00498 | 0.471 |
LIG_FHA_1 | 273 | 279 | PF00498 | 0.471 |
LIG_FHA_1 | 33 | 39 | PF00498 | 0.563 |
LIG_FHA_1 | 352 | 358 | PF00498 | 0.480 |
LIG_FHA_1 | 372 | 378 | PF00498 | 0.191 |
LIG_FHA_1 | 411 | 417 | PF00498 | 0.472 |
LIG_FHA_2 | 11 | 17 | PF00498 | 0.650 |
LIG_FHA_2 | 240 | 246 | PF00498 | 0.471 |
LIG_GBD_Chelix_1 | 82 | 90 | PF00786 | 0.283 |
LIG_Integrin_isoDGR_2 | 422 | 424 | PF01839 | 0.280 |
LIG_KLC1_Yacidic_2 | 192 | 197 | PF13176 | 0.471 |
LIG_LIR_Gen_1 | 313 | 322 | PF02991 | 0.471 |
LIG_LIR_Nem_3 | 221 | 226 | PF02991 | 0.471 |
LIG_LIR_Nem_3 | 313 | 318 | PF02991 | 0.471 |
LIG_NRBOX | 356 | 362 | PF00104 | 0.471 |
LIG_PCNA_yPIPBox_3 | 277 | 290 | PF02747 | 0.471 |
LIG_SH2_GRB2like | 317 | 320 | PF00017 | 0.557 |
LIG_SH2_PTP2 | 223 | 226 | PF00017 | 0.462 |
LIG_SH2_SRC | 195 | 198 | PF00017 | 0.471 |
LIG_SH2_SRC | 223 | 226 | PF00017 | 0.532 |
LIG_SH2_STAP1 | 105 | 109 | PF00017 | 0.483 |
LIG_SH2_STAT3 | 289 | 292 | PF00017 | 0.471 |
LIG_SH2_STAT3 | 456 | 459 | PF00017 | 0.503 |
LIG_SH2_STAT5 | 195 | 198 | PF00017 | 0.471 |
LIG_SH2_STAT5 | 212 | 215 | PF00017 | 0.446 |
LIG_SH2_STAT5 | 223 | 226 | PF00017 | 0.443 |
LIG_SH2_STAT5 | 289 | 292 | PF00017 | 0.471 |
LIG_SH2_STAT5 | 317 | 320 | PF00017 | 0.557 |
LIG_SH2_STAT5 | 456 | 459 | PF00017 | 0.503 |
LIG_SH3_3 | 221 | 227 | PF00018 | 0.471 |
LIG_SH3_3 | 89 | 95 | PF00018 | 0.472 |
LIG_SUMO_SIM_anti_2 | 258 | 265 | PF11976 | 0.483 |
LIG_SUMO_SIM_anti_2 | 358 | 365 | PF11976 | 0.471 |
LIG_SUMO_SIM_anti_2 | 428 | 437 | PF11976 | 0.501 |
LIG_SUMO_SIM_par_1 | 160 | 166 | PF11976 | 0.475 |
LIG_SUMO_SIM_par_1 | 308 | 313 | PF11976 | 0.471 |
LIG_SUMO_SIM_par_1 | 358 | 365 | PF11976 | 0.471 |
LIG_TRAF2_2 | 253 | 258 | PF00917 | 0.471 |
LIG_UBA3_1 | 161 | 168 | PF00899 | 0.557 |
MOD_CK1_1 | 261 | 267 | PF00069 | 0.543 |
MOD_CK1_1 | 371 | 377 | PF00069 | 0.419 |
MOD_CK2_1 | 10 | 16 | PF00069 | 0.649 |
MOD_CK2_1 | 372 | 378 | PF00069 | 0.413 |
MOD_GlcNHglycan | 1 | 4 | PF01048 | 0.578 |
MOD_GlcNHglycan | 105 | 108 | PF01048 | 0.268 |
MOD_GlcNHglycan | 199 | 202 | PF01048 | 0.313 |
MOD_GlcNHglycan | 444 | 447 | PF01048 | 0.426 |
MOD_GSK3_1 | 163 | 170 | PF00069 | 0.471 |
MOD_GSK3_1 | 258 | 265 | PF00069 | 0.471 |
MOD_GSK3_1 | 331 | 338 | PF00069 | 0.471 |
MOD_GSK3_1 | 368 | 375 | PF00069 | 0.527 |
MOD_GSK3_1 | 99 | 106 | PF00069 | 0.471 |
MOD_NEK2_1 | 322 | 327 | PF00069 | 0.471 |
MOD_NEK2_1 | 58 | 63 | PF00069 | 0.471 |
MOD_PIKK_1 | 163 | 169 | PF00454 | 0.557 |
MOD_PIKK_1 | 251 | 257 | PF00454 | 0.576 |
MOD_PKA_2 | 335 | 341 | PF00069 | 0.471 |
MOD_Plk_1 | 239 | 245 | PF00069 | 0.471 |
MOD_Plk_1 | 322 | 328 | PF00069 | 0.471 |
MOD_Plk_1 | 371 | 377 | PF00069 | 0.407 |
MOD_Plk_1 | 400 | 406 | PF00069 | 0.506 |
MOD_Plk_2-3 | 186 | 192 | PF00069 | 0.483 |
MOD_Plk_2-3 | 372 | 378 | PF00069 | 0.401 |
MOD_Plk_4 | 258 | 264 | PF00069 | 0.471 |
MOD_Plk_4 | 372 | 378 | PF00069 | 0.409 |
MOD_ProDKin_1 | 410 | 416 | PF00069 | 0.471 |
MOD_SUMO_for_1 | 4 | 7 | PF00179 | 0.581 |
MOD_SUMO_rev_2 | 102 | 112 | PF00179 | 0.471 |
MOD_SUMO_rev_2 | 437 | 445 | PF00179 | 0.481 |
TRG_DiLeu_BaEn_1 | 430 | 435 | PF01217 | 0.483 |
TRG_DiLeu_BaLyEn_6 | 356 | 361 | PF01217 | 0.471 |
TRG_ENDOCYTIC_2 | 180 | 183 | PF00928 | 0.471 |
TRG_ENDOCYTIC_2 | 223 | 226 | PF00928 | 0.462 |
TRG_ER_diArg_1 | 119 | 121 | PF00400 | 0.471 |
TRG_NES_CRM1_1 | 378 | 390 | PF08389 | 0.455 |
TRG_Pf-PMV_PEXEL_1 | 447 | 451 | PF00026 | 0.574 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I796 | Leptomonas seymouri | 44% | 95% |
A0A0N1IKW9 | Leptomonas seymouri | 92% | 100% |
A0A0S4JTM7 | Bodo saltans | 43% | 97% |
A0A0S4KMK6 | Bodo saltans | 82% | 100% |
A0A1X0P9Z8 | Trypanosomatidae | 86% | 100% |
A0A1X0PAP4 | Trypanosomatidae | 44% | 97% |
A0A3Q8IEM3 | Leishmania donovani | 99% | 100% |
A0A3Q8IFN2 | Leishmania donovani | 43% | 95% |
A0A422NEN7 | Trypanosoma rangeli | 86% | 100% |
A0A422NS36 | Trypanosoma rangeli | 44% | 97% |
A4HAX8 | Leishmania braziliensis | 43% | 95% |
A4HB68 | Leishmania braziliensis | 98% | 100% |
A4IA37 | Leishmania infantum | 43% | 95% |
A4IAB6 | Leishmania infantum | 99% | 100% |
C9ZLY0 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 85% | 100% |
C9ZM62 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 44% | 97% |
E9B552 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 43% | 95% |
E9B5D9 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 98% | 100% |
O17607 | Caenorhabditis elegans | 59% | 96% |
O94692 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 44% | 99% |
P0CR26 | Cryptococcus neoformans var. neoformans serotype D (strain JEC21 / ATCC MYA-565) | 61% | 95% |
P0CR27 | Cryptococcus neoformans var. neoformans serotype D (strain B-3501A) | 61% | 95% |
P0CR28 | Cryptococcus neoformans var. neoformans serotype D (strain JEC21 / ATCC MYA-565) | 44% | 99% |
P0CR29 | Cryptococcus neoformans var. neoformans serotype D (strain B-3501A) | 44% | 99% |
P60122 | Mus musculus | 70% | 100% |
P60123 | Rattus norvegicus | 70% | 100% |
P83571 | Danio rerio | 44% | 99% |
Q03940 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | 65% | 99% |
Q0IFL2 | Aedes aegypti | 68% | 100% |
Q12464 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | 43% | 97% |
Q16TA2 | Aedes aegypti | 44% | 99% |
Q29AK9 | Drosophila pseudoobscura pseudoobscura | 66% | 100% |
Q29DI0 | Drosophila pseudoobscura pseudoobscura | 44% | 96% |
Q2TBU9 | Bos taurus | 44% | 99% |
Q4I948 | Gibberella zeae (strain ATCC MYA-4620 / CBS 123657 / FGSC 9075 / NRRL 31084 / PH-1) | 43% | 97% |
Q4ICA8 | Gibberella zeae (strain ATCC MYA-4620 / CBS 123657 / FGSC 9075 / NRRL 31084 / PH-1) | 63% | 100% |
Q4P112 | Ustilago maydis (strain 521 / FGSC 9021) | 64% | 94% |
Q4P6N7 | Ustilago maydis (strain 521 / FGSC 9021) | 45% | 96% |
Q4Q2T4 | Leishmania major | 43% | 95% |
Q4WKH9 | Neosartorya fumigata (strain ATCC MYA-4609 / Af293 / CBS 101355 / FGSC A1100) | 40% | 98% |
Q4WPW8 | Neosartorya fumigata (strain ATCC MYA-4609 / Af293 / CBS 101355 / FGSC A1100) | 65% | 100% |
Q54UW5 | Dictyostelium discoideum | 43% | 98% |
Q5A0W7 | Candida albicans (strain SC5314 / ATCC MYA-2876) | 64% | 100% |
Q5AGZ9 | Candida albicans (strain SC5314 / ATCC MYA-2876) | 43% | 92% |
Q5BBV9 | Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139) | 64% | 100% |
Q5BGK3 | Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139) | 41% | 98% |
Q6BI60 | Debaryomyces hansenii (strain ATCC 36239 / CBS 767 / BCRC 21394 / JCM 1990 / NBRC 0083 / IGC 2968) | 62% | 100% |
Q6BSB8 | Debaryomyces hansenii (strain ATCC 36239 / CBS 767 / BCRC 21394 / JCM 1990 / NBRC 0083 / IGC 2968) | 42% | 96% |
Q6C3X6 | Yarrowia lipolytica (strain CLIB 122 / E 150) | 44% | 98% |
Q6CB52 | Yarrowia lipolytica (strain CLIB 122 / E 150) | 62% | 100% |
Q6CQA9 | Kluyveromyces lactis (strain ATCC 8585 / CBS 2359 / DSM 70799 / NBRC 1267 / NRRL Y-1140 / WM37) | 64% | 100% |
Q6CT29 | Kluyveromyces lactis (strain ATCC 8585 / CBS 2359 / DSM 70799 / NBRC 1267 / NRRL Y-1140 / WM37) | 43% | 98% |
Q6FSF1 | Candida glabrata (strain ATCC 2001 / CBS 138 / JCM 3761 / NBRC 0622 / NRRL Y-65) | 42% | 96% |
Q6FU78 | Candida glabrata (strain ATCC 2001 / CBS 138 / JCM 3761 / NBRC 0622 / NRRL Y-65) | 64% | 100% |
Q750R1 | Ashbya gossypii (strain ATCC 10895 / CBS 109.51 / FGSC 9923 / NRRL Y-1056) | 63% | 100% |
Q755G5 | Ashbya gossypii (strain ATCC 10895 / CBS 109.51 / FGSC 9923 / NRRL Y-1056) | 42% | 98% |
Q873C7 | Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) | 43% | 95% |
Q8AWW7 | Danio rerio | 70% | 100% |
Q8STP2 | Encephalitozoon cuniculi (strain GB-M1) | 51% | 100% |
Q8SU27 | Encephalitozoon cuniculi (strain GB-M1) | 38% | 100% |
Q8WZS3 | Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) | 62% | 100% |
Q9C0X6 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 66% | 100% |
Q9DE26 | Xenopus laevis | 70% | 100% |
Q9DE27 | Xenopus laevis | 44% | 99% |
Q9FMR9 | Arabidopsis thaliana | 68% | 100% |
Q9GZH2 | Caenorhabditis elegans | 40% | 100% |
Q9V3K3 | Drosophila melanogaster | 44% | 95% |
Q9VH07 | Drosophila melanogaster | 66% | 100% |
Q9WTM5 | Mus musculus | 44% | 99% |
Q9Y230 | Homo sapiens | 44% | 99% |
Q9Y265 | Homo sapiens | 70% | 100% |
V5B579 | Trypanosoma cruzi | 43% | 97% |
V5BQJ1 | Trypanosoma cruzi | 86% | 100% |